Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2009

01.09.2009

Defective Solubilization of Immune Complexes and Activation of the Complement System in Patients with Pulmonary Tuberculosis

verfasst von: P. Senbagavalli, S. T. Geetha, P. Venkatesan, V. D. Ramanathan

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Association between inherited deficiencies of the complement components and immune complex disease indicates the importance of the complement system in the handling of circulating immune complexes. High levels of circulating immune complexes are seen in pulmonary tuberculosis. This study is, therefore, aimed to look at the concentration of circulating immune complexes, the status of complement-mediated immune complex handling, and the extent of complement activation in untreated pulmonary tuberculosis compared to treated pulmonary tuberculosis patients and healthy controls.

Results

High immune complex levels, decreased complement-mediated solubilization, and increased activation of the complement system were observed in untreated tuberculosis patients.

Conclusions

The results obtained from the present study suggest that complement mediated solubilization is less in patients with tuberculosis, and this defective solubilization is likely to take part in a vicious cycle involving immune complex deposition and complement activation and, thus, may lead to disease progression depending on the nature of the defect.
Literatur
1.
Zurück zum Zitat Whaley K, Ahmed AE. Control of immune complexes by the classical pathway. Behring Inst Mitt. 1989;84:111–20.PubMed Whaley K, Ahmed AE. Control of immune complexes by the classical pathway. Behring Inst Mitt. 1989;84:111–20.PubMed
2.
Zurück zum Zitat Bottger EC, Hoffmann T, Hadding U, Bitter-Suermann D. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. J Clin Invest. 1986;78:689–95.PubMedCrossRef Bottger EC, Hoffmann T, Hadding U, Bitter-Suermann D. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. J Clin Invest. 1986;78:689–95.PubMedCrossRef
3.
Zurück zum Zitat Miller GW, Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975;72:418–22.PubMedCrossRef Miller GW, Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975;72:418–22.PubMedCrossRef
4.
Zurück zum Zitat Schifferli JA, Bartolotti SR, Peters DK. Inhibition of immune precipitation by complement. Clin Exp Immunol. 1980;42:387–94.PubMed Schifferli JA, Bartolotti SR, Peters DK. Inhibition of immune precipitation by complement. Clin Exp Immunol. 1980;42:387–94.PubMed
5.
Zurück zum Zitat May JJ, Katilus J, Henson PM, Dreisin RB. The purification and identification of circulating immune complexes in tuberculosis. Am Rev Respir Dis. 1983;128:920–5.PubMed May JJ, Katilus J, Henson PM, Dreisin RB. The purification and identification of circulating immune complexes in tuberculosis. Am Rev Respir Dis. 1983;128:920–5.PubMed
6.
Zurück zum Zitat Ramanathan VD, Parkash O, Ramu G, Parker D, Curtis J, Sengupta U, et al. Isolation and analysis of circulating immune complexes in leprosy. Clin Immunol Immunopathol. 1984;32:261–8.PubMedCrossRef Ramanathan VD, Parkash O, Ramu G, Parker D, Curtis J, Sengupta U, et al. Isolation and analysis of circulating immune complexes in leprosy. Clin Immunol Immunopathol. 1984;32:261–8.PubMedCrossRef
7.
Zurück zum Zitat Yoshinoya S, Cox RA, Pope RM. Circulating immune complexes in coccidioidomycosis. Detection and characterization. J Clin Invest. 1980;66:655–63.PubMedCrossRef Yoshinoya S, Cox RA, Pope RM. Circulating immune complexes in coccidioidomycosis. Detection and characterization. J Clin Invest. 1980;66:655–63.PubMedCrossRef
8.
Zurück zum Zitat Wemambu SN, Turk JL, Waters MF, Rees RJ. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet. 1969;2:933–5.PubMedCrossRef Wemambu SN, Turk JL, Waters MF, Rees RJ. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet. 1969;2:933–5.PubMedCrossRef
9.
Zurück zum Zitat Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Ramu G. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions. Indian J Lepr. 1998;70:153–60.PubMed Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Ramu G. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions. Indian J Lepr. 1998;70:153–60.PubMed
10.
Zurück zum Zitat Triolo G, Giardina E, Casiglia D, Scarantino G, Bompiani GD. Detection of the terminal fluid-phase complement complex, SC5b–9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor. Clin Exp Immunol. 1991;84:53–8.PubMed Triolo G, Giardina E, Casiglia D, Scarantino G, Bompiani GD. Detection of the terminal fluid-phase complement complex, SC5b–9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor. Clin Exp Immunol. 1991;84:53–8.PubMed
11.
Zurück zum Zitat Arason GJ, D'Ambrogio MS, Vikingsdottir T, Sigfusson A, Valdimarsson H. Enzyme immunoassays for measuring complement-dependent prevention of immune precipitation (PIP) and solubilization of preformed antigen-antibody complexes (SOL). J Immunol Methods. 1999;223:37–46.PubMedCrossRef Arason GJ, D'Ambrogio MS, Vikingsdottir T, Sigfusson A, Valdimarsson H. Enzyme immunoassays for measuring complement-dependent prevention of immune precipitation (PIP) and solubilization of preformed antigen-antibody complexes (SOL). J Immunol Methods. 1999;223:37–46.PubMedCrossRef
12.
Zurück zum Zitat Ramanathan VD, Parkash O, Tyagi P, Sengupta U, Ramu G. Activation of the human complement system by phenolic glycolipid 1 of Mycobacterium leprae. Microb Pathog. 1990;8:403–10.PubMedCrossRef Ramanathan VD, Parkash O, Tyagi P, Sengupta U, Ramu G. Activation of the human complement system by phenolic glycolipid 1 of Mycobacterium leprae. Microb Pathog. 1990;8:403–10.PubMedCrossRef
13.
Zurück zum Zitat Ramanathan VD, Sharma P, Ramu G, Sengupta U. Reduced complement-mediated immune complex solubilization in leprosy patients. Clin Exp Immunol. 1985;60:553–8.PubMed Ramanathan VD, Sharma P, Ramu G, Sengupta U. Reduced complement-mediated immune complex solubilization in leprosy patients. Clin Exp Immunol. 1985;60:553–8.PubMed
14.
Zurück zum Zitat Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Sengupta U, Ramu G. Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions. Int J Lepr Other Mycobact Dis. 1991;59:5–11.PubMed Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Sengupta U, Ramu G. Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions. Int J Lepr Other Mycobact Dis. 1991;59:5–11.PubMed
15.
Zurück zum Zitat Senbagavalli P, Geetha ST, Karunakaran K, Banu Rekha VV, Venkatesan P, Ramanathan VD. Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon. Clin Immunol. 2008;128:109–15.PubMedCrossRef Senbagavalli P, Geetha ST, Karunakaran K, Banu Rekha VV, Venkatesan P, Ramanathan VD. Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon. Clin Immunol. 2008;128:109–15.PubMedCrossRef
16.
Zurück zum Zitat Seth P, Srinivas R. CIC in cervical cancer. Simple method for detection and characterization. IJMR. 1981;73:926–9. Seth P, Srinivas R. CIC in cervical cancer. Simple method for detection and characterization. IJMR. 1981;73:926–9.
17.
Zurück zum Zitat Tyagi P, Ramanathan VD, Girdhar BK, Katoch K, Bhatia AS, Sengupta U. Activation of complement by circulating immune complexes isolated from leprosy patients. Int J Lepr Other Mycobact Dis. 1990;58:31–8.PubMed Tyagi P, Ramanathan VD, Girdhar BK, Katoch K, Bhatia AS, Sengupta U. Activation of complement by circulating immune complexes isolated from leprosy patients. Int J Lepr Other Mycobact Dis. 1990;58:31–8.PubMed
Metadaten
Titel
Defective Solubilization of Immune Complexes and Activation of the Complement System in Patients with Pulmonary Tuberculosis
verfasst von
P. Senbagavalli
S. T. Geetha
P. Venkatesan
V. D. Ramanathan
Publikationsdatum
01.09.2009
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2009
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9301-0

Weitere Artikel der Ausgabe 5/2009

Journal of Clinical Immunology 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.